Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (31-40 of 345) with videos related to

Pageof 35
Sort By:
Biochemical Society Transactions|January 17, 2019
H2 influenza viruses: designing vaccines against future H2 pandemicsZ Beau Reneer, Ted M Ross
Expert Review of Vaccines|May 24, 2016
Development of a Zika vaccineRalph A Tripp, Ted M Ross
Human Vaccines & Immunotherapeutics|April 12, 2018
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluationJames D Allen, Ted M Ross
Frontiers in Veterinary Science|August 19, 2021
Inherent Serum Inhibition of Influenza Virus NeuraminidasesAmanda L Skarlupka, Ted M Ross
Frontiers in Immunology|September 3, 2021
Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 VirusesJames D Allen, Ted M Ross
Frontiers in Immunology|March 27, 2024
mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020James D Allen, Ted M Ross
Scientific Reports|September 23, 2023
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineagesMichael A Carlock, Ted M Ross
Vaccine|May 9, 2026
Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B/Victoria strainsMichael A Carlock, Ted M Ross
Current Drug Targets. Infectious Disorders|May 29, 2003
Particle-based vaccines for HIV-1 infectionKelly R Young, Ted M Ross
Scientific Reports|March 3, 2021
Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) virusesJames D Allen, Ted M Ross
Pageof 35

Showing results (31-40 of 345) with videos related to

Sort By:
Pageof 35
Biochemical Society Transactions|January 17, 2019
H2 influenza viruses: designing vaccines against future H2 pandemicsZ Beau Reneer, Ted M Ross
Expert Review of Vaccines|May 24, 2016
Development of a Zika vaccineRalph A Tripp, Ted M Ross
Human Vaccines & Immunotherapeutics|April 12, 2018
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluationJames D Allen, Ted M Ross
Frontiers in Veterinary Science|August 19, 2021
Inherent Serum Inhibition of Influenza Virus NeuraminidasesAmanda L Skarlupka, Ted M Ross
Frontiers in Immunology|September 3, 2021
Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 VirusesJames D Allen, Ted M Ross
Frontiers in Immunology|March 27, 2024
mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020James D Allen, Ted M Ross
Scientific Reports|September 23, 2023
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineagesMichael A Carlock, Ted M Ross
Vaccine|May 9, 2026
Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B/Victoria strainsMichael A Carlock, Ted M Ross
Current Drug Targets. Infectious Disorders|May 29, 2003
Particle-based vaccines for HIV-1 infectionKelly R Young, Ted M Ross
Scientific Reports|March 3, 2021
Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) virusesJames D Allen, Ted M Ross
Pageof 35